中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
22期
130-132,135
,共4页
艾司西酞普兰%西酞普兰%抑郁症%临床疗效%安全性
艾司西酞普蘭%西酞普蘭%抑鬱癥%臨床療效%安全性
애사서태보란%서태보란%억욱증%림상료효%안전성
Escitalopram%Citalopram%Depression%Clinical effect%Safety
目的:观察艾司西酞普兰与西酞普兰治疗抑郁症的临床疗效,以期为抑郁症的临床治疗提供借鉴经验。方法选择2012年10月~2014年9月本院精神科收治的90例抑郁症患者,将其按照随机数字表法分为观察组和对照组,每组45例。对照组采用口服氢溴酸西酞普兰片治疗,观察组采用口服草酸艾司西酞普兰片治疗,两组均治疗6周后观察临床疗效和不良反应,并比较两组治疗前后汉密尔顿焦虑量表(HAMA)和临床总体印象量表-病情严重程度量表(CGI-SI)评分。结果两组的痊愈率和治疗总有效率差异均无统计学意义(P跃0.05);治疗后,两组HAMA、CGI-SI评分均较治疗前显著降低,差异有统计学意义(P<0.05),但两组治疗后的比较,差异无统计学意义(P跃0.05);两组不良反应发生率及治疗后不良反应量表总分差异无统计学意义(P跃0.05)。结论艾司西酞普兰与西酞普兰治疗抑郁症的效果相当,均可改善患者的病情和焦虑症状,且不良反应轻微,可以用于抑郁症的治疗。
目的:觀察艾司西酞普蘭與西酞普蘭治療抑鬱癥的臨床療效,以期為抑鬱癥的臨床治療提供藉鑒經驗。方法選擇2012年10月~2014年9月本院精神科收治的90例抑鬱癥患者,將其按照隨機數字錶法分為觀察組和對照組,每組45例。對照組採用口服氫溴痠西酞普蘭片治療,觀察組採用口服草痠艾司西酞普蘭片治療,兩組均治療6週後觀察臨床療效和不良反應,併比較兩組治療前後漢密爾頓焦慮量錶(HAMA)和臨床總體印象量錶-病情嚴重程度量錶(CGI-SI)評分。結果兩組的痊愈率和治療總有效率差異均無統計學意義(P躍0.05);治療後,兩組HAMA、CGI-SI評分均較治療前顯著降低,差異有統計學意義(P<0.05),但兩組治療後的比較,差異無統計學意義(P躍0.05);兩組不良反應髮生率及治療後不良反應量錶總分差異無統計學意義(P躍0.05)。結論艾司西酞普蘭與西酞普蘭治療抑鬱癥的效果相噹,均可改善患者的病情和焦慮癥狀,且不良反應輕微,可以用于抑鬱癥的治療。
목적:관찰애사서태보란여서태보란치료억욱증적림상료효,이기위억욱증적림상치료제공차감경험。방법선택2012년10월~2014년9월본원정신과수치적90례억욱증환자,장기안조수궤수자표법분위관찰조화대조조,매조45례。대조조채용구복경추산서태보란편치료,관찰조채용구복초산애사서태보란편치료,량조균치료6주후관찰림상료효화불량반응,병비교량조치료전후한밀이돈초필량표(HAMA)화림상총체인상량표-병정엄중정도량표(CGI-SI)평분。결과량조적전유솔화치료총유효솔차이균무통계학의의(P약0.05);치료후,량조HAMA、CGI-SI평분균교치료전현저강저,차이유통계학의의(P<0.05),단량조치료후적비교,차이무통계학의의(P약0.05);량조불량반응발생솔급치료후불량반응량표총분차이무통계학의의(P약0.05)。결론애사서태보란여서태보란치료억욱증적효과상당,균가개선환자적병정화초필증상,차불량반응경미,가이용우억욱증적치료。
Objective To observe the clinical efficacy of escitalopram and citalopram in the treatment of depression in order to enrich the experience of clinical treatment on depression. Methods 90 patients with depression in our hospital department of psychiatric from October 2012 to September 2014 were selected and evenly divided into observation group and control group by random number table,45 cases in each group.In the control group,oral administration of citalopram hydrobromide was provided,while in the observation group,escitalopram oxalate for oral administration was applied.After 6-week treatment,the clinical efficacy and adverse reaction in two groups was observed,and scores of Hamilton anxiety scale (HAMA) and clinical general impression-severity of illness scale (CGI-SI) between two groups before and after treatment was observed and compared. Results There was no significant difference in cure rate or total effective rate (P>0.05).After therapy,scores of HAMA and CGI-SI was greatly decreased compared with those before treatment with statistical difference (P<0.05),but didn’t display significant difference after treatment in both groups (P>0.05).Adverse reactions in two groups showed no important difference as well as score of emergent symptom scale (P>0.05). Conclusion Effect of escitalopram on treating depression is tantamount to citalopram.It can improve patient’s disease condition and anxiety with mild adverse reactions,which can be used to treat depression.